OncoMatch/Clinical Trials/NCT07308717

Gabapentin And Breast Surgery Decision Architecture Randomization Trial (GABS-DART) Protocol

Is NCT07308717 recruiting? Yes, currently enrolling (May 2026). This Phase 4 trial studies non-drug interventions for breast cancer.

Phase 4RecruitingMemorial Sloan Kettering Cancer CenterNCT07308717Data as of May 2026

This study aims to assess whether gabapentin should be a standard component of peri-operative pain control in mastectomy patients at Memorial Sloan Kettering Cancer Center.

Check if I qualify

Extracted eligibility criteria

Cancer type

Breast Carcinoma

Structured fields extracted by AI. May contain errors — verify against the official protocol.

US trial sites

Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) · Basking Ridge, New Jersey
Memorial Sloan Kettering Monmouth (Limited protocol activities) · Middletown, New Jersey
Memorial Sloan Kettering Bergen (Limited Protocol Activities) · Montvale, New Jersey
Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activities) · Commack, New York
Memorial Sloan Kettering Westchester (Limited Protocol Activities) · Harrison, New York

Showing up to 5 US sites. See all sites on ClinicalTrials.gov →

Could you qualify for this trial?

Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.

Check if I qualify